SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.
LATEST NEWS
April 15, 2024 —
Nuclear Medicine Funding Language in CDRMP
SNMMI is excited to share that with the signing H.R. 2882, which included the FY 2024 Defense Appropriations bill, SNMMI’s CDMRP report language has been approved.
March 13, 2024 —
HPRA March 2024 Newsletter
SNMMI Health Policy and Regulatory Affairs Department has released its March 2024 newsletter. Highlights include updates on CMS meetings, prior authorization, and the Nuclear Medicine Clarification Act of 2023.
February 27, 2024 —
Biden Administration Finalizes Rule on Prior Authorization
The Biden administration finalized a rule that will simplify Medicare Advantage, Medicaid, and other government-sponsored health plans’ use of prior authorization.
January 3, 2024 —
CMS Removes NCD 220.6.20 From Publication 100-03
CMS removed NCD 220.6.20 from Publication 100-03, ending CED for PET beta amyloid imaging and permitting Medicare coverage determinations to be made by the Medicare Administrative Contractors.
December 14, 2023 —
HPRA December 2023 Newsletter
SNMMI Health Policy and Regulatory Affairs Department released its December 2023 Newsletter. Highlights include updates on CMS HOPPS Rules, The FIND Act, and other legislative initiatives.
September 7, 2023 —
SNMMI Submits Comments to NRC on Patient Release, Injection Extravasations
SNMMI has submitted comments to the Nuclear Regulatory Commission (NRC) on several important issues: its draft regulatory guide on release of patients and its rulemaking on reporting of nuclear medicine injection extravasations as medical events.